As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Learn more: PMC Disclaimer | PMC Copyright Notice
JCI Insight. 2022 Oct 24; 7(20): e165502.
Published online 2022 Oct 24. doi: 10.1172/jci.insight.165502
PMCID: PMC9744256
PMID: 36278491
Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy
This corrects the article "Immunopathogenesis of hidradenitis suppurativa and response to anti–TNF-α therapy" in volume 5, e139932.
Original citation: JCI Insight. 2020;5(19):e139932. https://doi.org/10.1172/jci.insight.139932
Citation for this corrigendum: JCI Insight. 2022;7(20):e165502. https://doi.org/10.1172/jci.insight.165502
The authors recently became award of inconsistencies in Figure 9, C and D, and have identified an error in which the data from a nonresponder had been inadvertently plotted in the responder column. The correct figure parts are below. The HTML and PDF versions have been updated online. The authors have stated that all conclusions of the paper remain the same.
The authors regret the errors.
Version Changes
Version 1. 10/24/2022
Electronic publication
Footnotes
See the related article at Immunopathogenesis of hidradenitis suppurativa and response to anti-TNFα therapy.
Articles from JCI Insight are provided here courtesy of American Society for Clinical Investigation